IP Library Granted Patent US 9,724,475
Granted Patent B2
US 9,724,475 · App. 13/203,707 · Granted Aug 8, 2017

Drug delivery management systems and methods

Inventors: Peter Krulevitch (Pleasanton, CA); Ulrich Kraft (Hofheim, DE); Robert Wilk (Sierra Village, CA); Zara Sieh (San Ramon, CA); Mitch Zhao (San Jose, CA)
Assignee: LifeScan, Inc.
A61M5/315A61M5/24A61M5/3129A61M5/31525G06F19/3468A61B5/002A61B5/14532A61M5/3146A61M5/31551A61M2005/3126A61M2005/3142A61M2205/14A61M2205/18A61M2205/215A61M2205/3317A61M2205/3553A61M2205/3561A61M2205/3569A61M2205/3584A61M2205/3592A61M2205/52A61M2205/581A61M2205/583A61M2205/584A61M2205/6054A61M2205/6081A61M2205/8212A61M2209/04G01D5/1655
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,724,475
App. No.
13/203,707
Filed
Sep 8, 2011
Granted
Aug 8, 2017
Kind
B2
Art Unit
3763
USPC
604/504
Abstract

Various embodiments of a “smart” drug delivery pen are provided which include a drug delivery pen having an inertial sensor or accelerometer. A system is also provided that includes the smart drug pen in conjunction with a data management unit(s) DMU. Various exemplary methods for use of the pens and systems are also described and illustrated.

Claims (60)

1. A drug delivery pen for confirming a dosage delivery protocol, the pen comprising:

a pen housing that extends from a first end to a second end along a longitudinal axis, the housing being coupled to a drug cartridge disposed proximate the first end, the drug cartridge including a volume of one or more drugs disposed therein;

a microprocessor disposed in the housing and operatively connected to a power source and a memory; and

an inertial sensor connected to the housing and in electronic communication with the microprocessor, wherein the microprocessor confirms the dosage delivery protocol from output signals of the inertial sensor by:

determining whether the housing has been shaken back and forth a predetermined number of times along the longitudinal axis to mix the one or more drugs disposed in the cartridge; and

determining whether the pen housing, including the cartridge, has been oriented topmost and generally vertically with respect to a ground during a priming operation, wherein the microprocessor distinguishes whether the pen has delivered a priming shot or a dosage of the one or more drugs.

2. A drug delivery pen for confirming a dosage delivery protocol, the pen comprising:

a pen housing that extends from a first end to a second end along a longitudinal axis, the housing being coupled to a drug cartridge disposed proximate the first end, the drug cartridge including a volume of one or more drugs disposed therein;

a plunger rod having a portion disposed in the housing and at least a portion of the plunger rod coupled to the drug cartridge;

a dosage selector mounted to the housing and coupled to the plunger rod;

a microprocessor disposed in the housing and operatively connected to a power source and a memory;

a momentary switch coupled to the plunger rod and electrically connected to the microprocessor so that actuation of the plunger rod to deliver drug causes the switch to be actuated and allows the microprocessor to detect actuation of the plunger rod; and

an acceleration sensor connected to the housing and in electronic communication with the microprocessor, wherein the microprocessor confirms the dosage delivery protocol from output signals of the acceleration sensor by:

determining whether the housing has been shaken back and forth a predetermined number of times along the longitudinal axis to mix the one or more drugs disposed in the cartridge; and

determining whether the pen housing, including the cartridge, has been oriented topmost and generally vertically with respect to a ground during a priming operation, wherein the microprocessor distinguishes whether the pen has delivered a priming shot or a dosage of the one or more drugs.

3. The drug delivery pen of one of claim 1 or claim 2 , in which the drug cartridge contains a drug selected from a group consisting of long acting insulin, rapid acting insulin, long and rapid acting mixed insulin, neutral protamine Hagedorn (NPH), growth hormone, glucagon-like peptide (GLP-1) analogs, pramlintide, or combinations thereof.

4. The drug delivery pen of claim 1 , further comprising:

at least a portion of a plunger rod coupled to the drug cartridge; and

a dosage selector coupled to the plunger rod.

5. The drug delivery pen of one of claim 1 or claim 2 , further comprising a transceiver disposed in the housing and coupled to the microprocessor to transmit and receive data relating to dosage delivery of a drug dosage in the drug cartridge to a data management unit remote from the drug delivery pen.

6. The drug delivery pen of one of claim 1 or claim 2 , further comprising a dosage indicator display provided on the pen housing, the dosage indicator display providing a representation of dosage selected by a user of the drug delivery pen.

7. The drug delivery pen of one of claim 1 or claim 2 , further comprising a Radio-Frequency-Identification tag coupled to the drug cartridge and configured to store information selected from a group including type of drug(s) in the cartridge, volume of drug in the cartridge, expiration date, batch date, lot number, manufacturer identification or combinations thereof.

8. The drug delivery pen of claim 2 , further comprising a dosage sensor attached to the dosage selector of the pen and coupled to the microprocessor so as to provide dosage delivery data upon displacement of the dosage selector.

9. A diabetes management system comprising:

a data management unit including:

a memory;

a processor coupled to the memory;

a display coupled to the processor; and

a transceiver to receive and transmit data; and

a drug delivery pen for confirming a dosage delivery protocol, the pen comprising:

a pen housing that extends from a first end to a second end along a longitudinal axis, the housing being coupled to a drug cartridge disposed proximate the first end, the pen housing having a dosage indicator window and a dosage selector coupled to the plunger rod;

a memory;

a microprocessor coupled to the memory of the pen; and

an inertial sensor connected to the housing and in electronic communication with the microprocessor, wherein the microprocessor confirms the dosage delivery protocol from output signals of the inertial sensor by:

determining whether the housing has been shaken back and forth a predetermined number of times along the longitudinal axis to mix the one or more drugs disposed in the cartridge; and

determining whether the pen housing, including the cartridge, has been oriented topmost and generally vertically with respect to a ground during a priming operation, wherein the microprocessor distinguishes whether the pen has delivered a priming shot or a dosage of the one or more drugs.

10. The system of claim 9 , further comprising a dosage sensor attached to the dosage selector of the pen and coupled to the processor so as to provide data upon displacement of the dosage selector.

11. The system of claim 10 , wherein the transceiver transmits and receives data relating to dosage delivery of a drug dosage in the drug cartridge to the data management unit.

12. The system of claim 9 , in which the drug cartridge contains a drug selected from a group consisting essentially of long acting insulin, rapid acting insulin, long and rapid acting mixed insulin, neutral protamine Hagedorn (NPH), growth hormone, glucagon-like peptide (GLP-1) analogs, pramlintide, or combinations thereof.

13. The system of claim 9 , in which the data management unit further comprises an analyte sensor coupled to the processor to provide signals indicative of analyte value in a user's biological fluid.

14. The system of claim 9 , in which the data management unit comprises a mobile phone.

15. The system of claim 9 , in which the data management unit comprises a mobile computer.

16. The system of claim 9 , in which the data management unit comprises a network server located at a remote location from the communication module.

17. The system of claim 9 , further comprising a radio-frequency-identification (RFID) tag being coupled to the drug cartridge to store data selected from a group including a type of drug(s) in the cartridge, volume of drug in the cartridge, expiration date, batch date, lot number, manufacturer identification or combinations thereof.

18. The system of claim 17 , further comprising a radio-frequency-identification tag (RFID) reader disposed on one of the pen and the data management unit to interrogate the RFID tag for transfer of the information stored on the RFID tag.

19. A diabetes management system comprising:

a data management unit including:

a memory;

a processor coupled to the memory;

a display coupled to the processor; and

a transceiver to receive and transmit data;

a radio-frequency-identification reader; and

a drug delivery pen comprising:

a pen housing that extends from a first end to a second end along a longitudinal axis, the housing being coupled to a drug cartridge disposed proximate the first end, the pen housing having a dosage indicator window and a dosage selector coupled to the plunger rod;

a memory;

a microprocessor coupled to the memory of the pen;

a radio-frequency-identification tag attached to the drug cartridge and configured to store data selected from a group including a type of drug(s) in the cartridge, volume of drug in the cartridge, expiration date, batch date, lot number, manufacturer identification or combinations thereof; and

an inertial sensor connected to the housing and in electronic communication with the microprocessor, wherein the microprocessor confirms the dosage delivery protocol from output signals of the inertial sensor by:

determining whether the housing has been shaken back and forth a predetermined number of times along the longitudinal axis to mix the one or more drugs disposed in the cartridge; and

determining whether the pen housing, including the cartridge, has been oriented topmost and generally vertically with respect to a ground during a priming operation, wherein the microprocessor distinguishes whether the pen has delivered a priming shot or a dosage of the one or more drugs.

Assignments (15)
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: ANKURA TRUST COMPANY, LLC
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0495 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0316 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSBWILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073928/0626 →
ASSIGNMENT OF PATENT SECURITY INTERESTS (1ST LIEN) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 072567/0482 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 063740, FRAME 0080 Recorded Nov 12, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 069340/0243 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 047179, FRAME 0150 Recorded Nov 11, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: ANKURA TRUST COMPANY, LLC, AS SUCCESSOR AGENT
Reel/Frame 069314/0022 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY LIST BY ADDING PATENTS 6990849;7169116; 7351770;7462265;7468125; 7572356;8093903; 8486245;8066866;AND DELETE 10881560. PREVIOUSLY RECORDED ON REEL 050836 FRAME 0737. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2023
From: LIFESCAN INC.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 064782/0443 →
RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836 Recorded Jun 28, 2023
From: BANK OF AMERICA, N.A.
To: LIFESCAN IP HOLDINGS, LLC; JANSSEN BIOTECH, INC.; JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 064206/0176 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded May 23, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063740/0080 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded May 22, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063712/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: LIFESCAN INC.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 050836/0737 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: CILAG GMBH INTERNATIONAL
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 050837/0001 →
SECURITY AGREEMENT Recorded Oct 3, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047186/0836 →
SECURITY AGREEMENT Recorded Oct 2, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047179/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2011
From: KRULEVITCH, PETER; WILK, ROBERT; KRAFT, ULRICH; SIEH, ZARA; ZHAO, MITCH
To: LIFESCAN, INC.
Reel/Frame 026875/0390 →
Continuity (5)
Provisional Application 61156386 · Feb 27, 2009
Provisional Application 61156421 · Feb 27, 2009
Provisional Application 61156472 · Feb 27, 2009
Provisional Application 61164250 · Mar 27, 2009
Related Publication 20110313395A1 · Dec 22, 2011